Cyclin-dependent kinase inhibitor 1
The combination of forward signaling through EphB4 and reverse signaling through Ephrin-B2 promotes in vivo mammary tumor growth and tumor-associated angiogenesis
with C-terminal 8*His NDCPHKKSATLLPSFTVTPTVTESTGTTSHRTTKSHKTTTHRTTTTGTTSHGPTTATHNPTTTSHGNVTVHPTSNSTATSQGPSTATHSPATTSHGNATVHPTSNSTATSPGFTSSAHPEPPPPSPSPSPTSKETIGDYTWTNGSQPCVHLQAQIQIRVMYTTQGGGEAWGISVLNPNKTKVQGSCEGAHPHLLLSFPYGHLSFGFMQDLQQKVVYLSYMAVEYNVSFPHAAQWTFSAQNASLRDLQAPLGQSFSCSNSSIILSPAVHLDLLSLRLQAAQLPHTGVFGQSFSCPSDRSGGGSHHHHHHHH
more appropriate cell lysis conditions may be selected depending on the cell line or the subsequent use of the trapped antigen
Species Mouse Amino Acid Sequence SVYDFFVWL
VEGF Receptor 2/FLK-1 Recombinant Rabbit mAb (S-R400) Size:100μl Cyclin-dependent kinase inhibitor 1Product Specification Host Rabbit Synonyms Vascular endothelial growth factor receptor 2, VEGFR 2, Fetal liver kinase 1 (FLK 1), Kinase insert domain receptor (KDR), Protein tyrosine kinase receptor flk 1, CD309, KDR Location Cell membrane Accession P35968 Clone Number S R400 Antibody Type Recombinant mAb Isotype IgG Application IHC P Reactivity Hu Purification Protein A Concentration 0. 5 mg ml Conjugation Unconjugated Physical Appearance Liquid